Omnicell, Inc.
OMCL Healthcare Health Information Services
Omnicell, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 6.53% from fiscal 2024. In the quarter to June 2026, revenue grew 7.45%, EPS grew 341.7%, free cash flow grew 107.9% and total debt fell 50.8%, each against the same quarter a year earlier.
Follow OMCL
Omnicell, Inc. (OMCL) EV/Sales
As of 16 October 2026, Omnicell, Inc. (OMCL) trades at a EV/Sales of 1.3×. Over the past ten years it has ranged from 1.0× (May 2025) to 7.5× (November 2021); the current reading is higher than 10% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.9× | 3.47% |
| FY2024 | 1.8× | 15.79% |
| FY2023 | 1.6× | (19.78%) |
| FY2022 | 2.0× | (72.40%) |
| FY2021 | 7.1× | 23.90% |
| FY2020 | 5.7× | 54.52% |
| FY2019 | 3.7× | 17.11% |
| FY2018 | 3.2× | 10.83% |
| FY2017 | 2.9× | 37.53% |
| FY2016 | 2.1× | (2.63%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.6× | 18.21% |
| Mar 2026 | 1.3× | (29.84%) |
| Dec 2025 | 1.9× | 43.00% |
| Sep 2025 | 1.3× | 14.66% |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| TDOC Teladoc Health, Inc. compare | 0.9× |
| PRVA Privia Health Group, Inc. compare | 1.0× |
| OMCL Omnicell, Inc. | 1.3× |
| PHR Phreesia, Inc. compare | 1.5× |
| GDRX GoodRx Holdings, Inc. compare | 1.7× |
| OMDA Omada Health, Inc. compare | 2.8× |
| HSTM HealthStream, Inc. compare | 2.9× |
| CERT Certara, Inc. compare | 3.7× |
| SDGR Schrodinger, Inc. compare | 4.9× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)